Endocrine Regulation of Alcohol Intake

酒精摄入的内分泌调节

基本信息

批准号：
10321634
负责人：
Matthew Joseph Potthoff
金额：
$ 43.72万
依托单位：
UNIVERSITY OF IOWA
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-01-10 至 2024-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10321634
关键词：
Acute Address Adolescent and Young Adult Adult Affect Alcohol consumption Alcoholic Intoxication Alcohols Amygdaloid structure Animal Model Automobile Driving Behavior Behavioral Biological Assay Brain Cardiovascular Diseases Cells Chronic Consummatory Behavior Consumption Data Diagnosis Dissection Dopamine Drug usage Economic Burden Endocrine Enterobacteria phage P1 Cre recombinase Ethanol Etiology Feedback Genes Genetic Polymorphism Genetic Variation Glutamates Goals Grant Health Care Costs Healthcare Heavy Drinking Hormonal Hormones Human Individual Knock-out Knockout Mice Liver Malignant Neoplasms Measures Mediating Metabolic Metabolic syndrome Metabolism Modeling Mus National Institute on Alcohol Abuse and Alcoholism Neuraxis Neurons Nucleus Accumbens Pathologic Pathway interactions Peripheral Pharmacologic Substance Pharmacology Physiological Physiology Population Prevalence Production Regulation Rewards Role Series Signal Pathway Signal Transduction Single Nucleotide Polymorphism Synaptic Transmission System Techniques Testing Therapeutic Time Tissues United States Ventral Tegmental Area Work alcohol abuse therapy alcohol exposure alcohol use disorder base binge drinking cancer risk designer receptors exclusively activated by designer drugs fibroblast growth factor 21 genomic locus improved in vivo innovation insight mesolimbic system mouse model neural circuit new therapeutic target novel preference prevent productivity loss promoter receptor targeted treatment therapeutic target tool

项目摘要

PROJECT SUMMARY / ABSTRACT In the United States, alcohol use disorder (AUD) affects ~15% of adults with the prevalence of binge drinking on the rise in adolescents and young adults. AUD represents a major issue to healthcare given that chronic excessive alcohol consumption in humans is associated with cardiovascular disease, metabolic syndrome, and cancer while acute alcohol intoxication can prove lethal. Economically, AUD represents a massive burden due to loss of productivity and associated healthcare costs. Recently, the endocrine hormone fibroblast growth factor 21 (FGF21), known for its potent metabolic effects, was found to significantly reduce alcohol consumption via signaling through its obligate co-receptor, β-klotho, in the brain. Importantly, single nucleotide polymorphisms (SNPs) in both the FGF21 and β-klotho genomic loci are highly associated with increased alcohol consumption in humans. Our preliminary data demonstrates that FGF21 treatment markedly suppresses alcohol consumption in mice previous subjected to chronic alcohol exposure. Furthermore, excessive alcohol consumption promotes FGF21 secretion from the liver representing a homeostatic feedback loop to regulate alcohol consumption. However, the mechanism of FGF21 action in the brain and the neuronal target(s) for these effects has not been determined. The overall goal of this proposal is to identify the neural circuit(s) regulating FGF21-mediated suppression of alcohol intake. The aims of this grant are to 1) determine the direct neuronal target(s) of FGF21 in the CNS mediating inhibition of alcohol intake, and 2) determine how FGF21 modulates reward circuits to regulate alcohol intake and preference. To accomplish these aims, we have generated novel animal models and tools to examine these experimental aims. These studies will provide new fundamental insights into the regulation of alcohol intake by peripheral endocrine signals acting on the central nervous system. In addition, these studies may identify novel therapeutic targets for the treatment of AUD.

项目概要/摘要在美国，大约 15% 的成年人患有酒精使用障碍 (AUD)，酗酒盛行鉴于慢性病，青少年和年轻人的增加是医疗保健的一个主要问题。人类过量饮酒与心血管疾病、代谢综合征和澳元可能会导致癌症，而急性酒精中毒可能会致命。最近，内分泌激素成纤维细胞的生长导致生产力损失和相关的医疗费用。因子 21 (FGF21) 以其强大的代谢作用而闻名，被发现可以显着减少酒精摄入量通过大脑中的专性辅助受体 β-klotho 发出信号来消耗。 FGF21 和 β-klotho 基因组位点的多态性 (SNP) 与增加的我们的初步数据表明 FGF21 治疗可显着改善人类饮酒量。抑制先前长期接触酒精的小鼠的饮酒量。过量饮酒会促进肝脏分泌 FGF21，这是一种稳态反馈然而，FGF21 在大脑和神经元中的作用机制。这些影响的目标尚未确定。该提案的总体目标是确定神经网络。调节 FGF21 介导的酒精摄入抑制的电路此项资助的目的是 1) 确定。 FGF21 在中枢神经系统中介导酒精摄入抑制的直接神经元靶点，以及 2) 确定如何 FGF21 调节奖赏回路来调节酒精摄入量和偏好。为了实现这些目标，我们。已经产生了新的动物模型和工具来检查这些实验目的。关于外周内分泌信号作用于酒精摄入调节的新基本见解此外，这些研究可能会确定治疗中枢神经系统的新治疗靶点。澳元。